Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors.

Nasi G, Ahmed T, Rasini E, Fenoglio D, Marino F, Filaci G, Cosentino M.

J Neuroimmunol. 2019 Jul 15;332:233-241. doi: 10.1016/j.jneuroim.2019.02.007. Epub 2019 Mar 9.

PMID:
30954278
2.

Immunological profile of an infant treated with integrase inhibitor from the neonatal period.

Taramasso L, Dentone C, Tatarelli P, Bruzzone B, Marras F, De Maria A, Gotta C, Castagnola E, Filaci G, Viscoli C, Fenoglio D, Di Biagio A.

J Virus Erad. 2019 Jan 1;5(1):47-49. No abstract available.

3.

Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV.

Filaci G, Fenoglio D, Taramasso L, Indiveri F, Di Biagio A.

Front Immunol. 2018 Oct 23;9:2447. doi: 10.3389/fimmu.2018.02447. eCollection 2018.

4.

Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients.

Dentone C, Di Biagio A, Cozzi Lepri A, Fenoglio D, Filaci G, Lichtner M, Carrara S, Giacometti A, Sighinolfi L, Marchetti G, Antinori A, D'arminio Monforte A; ICONA Foundation Study Group.

HIV Clin Trials. 2018 Aug;19(4):158-162. doi: 10.1080/15284336.2018.1488453. Epub 2018 Nov 13.

PMID:
30422095
5.

White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder.

Magioncalda P, Martino M, Tardito S, Sterlini B, Conio B, Marozzi V, Adavastro G, Capobianco L, Russo D, Parodi A, Kalli F, Nasi G, Altosole T, Piaggio N, Northoff G, Fenoglio D, Inglese M, Filaci G, Amore M.

Brain Behav Immun. 2018 Oct;73:192-204. doi: 10.1016/j.bbi.2018.04.017. Epub 2018 May 1.

PMID:
29723656
6.

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

D'Arena G, Vitale C, Coscia M, Festa A, Di Minno NMD, De Feo V, Caraglia M, Calapai G, Laurenti L, Musto P, Di Minno G, Fenoglio D.

J Immunol Res. 2017;2017:1832968. doi: 10.1155/2017/1832968. Epub 2017 Dec 21. Review.

7.

CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F, Nasi G, Curto M, Cenderello G, De Leo P, Bartolacci V, Orofino G, Nicolini LA, Taramasso L, Fiorillo E, Orrù V, Traverso P, Bruzzone B, Ivaldi F, Mantia E, Guerra M, Negrini S, Giacomini M, Bhagani S, Filaci G.

J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov 2.

8.

A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.

Manzo E, Cutignano A, Pagano D, Gallo C, Barra G, Nuzzo G, Sansone C, Ianora A, Urbanek K, Fenoglio D, Ferrera F, Bernardi C, Parodi A, Pasquale G, Leonardi A, Filaci G, De Palma R, Fontana A.

Sci Rep. 2017 Jul 24;7(1):6286. doi: 10.1038/s41598-017-05969-8.

9.

Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis.

Negrini S, Fenoglio D, Parodi A, Kalli F, Battaglia F, Nasi G, Curto M, Tardito S, Ferrera F, Filaci G.

Front Immunol. 2017 Jan 19;8:18. doi: 10.3389/fimmu.2017.00018. eCollection 2017.

10.

Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.

Colla R, Izzotti A, De Ciucis C, Fenoglio D, Ravera S, Speciale A, Ricciarelli R, Furfaro AL, Pulliero A, Passalacqua M, Traverso N, Pronzato MA, Domenicotti C, Marengo B.

Oncotarget. 2016 Oct 25;7(43):70715-70737. doi: 10.18632/oncotarget.12209.

11.

AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.

Conteduca G, Fenoglio D, Parodi A, Battaglia F, Kalli F, Negrini S, Tardito S, Ferrera F, Salis A, Millo E, Pasquale G, Barra G, Damonte G, Indiveri F, Ferrone S, Filaci G.

Oncotarget. 2016 Sep 20;7(38):60872-60884. doi: 10.18632/oncotarget.11506.

12.

Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib.

Furfaro AL, Piras S, Domenicotti C, Fenoglio D, De Luigi A, Salmona M, Moretta L, Marinari UM, Pronzato MA, Traverso N, Nitti M.

PLoS One. 2016 Mar 29;11(3):e0152465. doi: 10.1371/journal.pone.0152465. eCollection 2016.

13.

Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.

Parodi A, Traverso P, Kalli F, Conteduca G, Tardito S, Curto M, Grillo F, Mastracci L, Bernardi C, Nasi G, Minaglia F, Simonato A, Carmignani G, Ferrera F, Fenoglio D, Filaci G.

Oncotarget. 2016 Feb 9;7(6):6424-35. doi: 10.18632/oncotarget.7024.

14.

Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system.

Dentone C, Fenoglio D, Schenone E, Cenderello G, Prinapori R, Signori A, Parodi A, Kalli F, Battaglia F, Feasi M, Bruzzone B, Viscoli C, Filaci G, Di Biagio A.

HIV Clin Trials. 2015 Oct;16(5):190-6. doi: 10.1179/1945577115Y.0000000005. Epub 2015 Sep 13.

PMID:
26365593
15.

Impaired immune response to Candida albicans in cells from Fanconi anemia patients.

Parodi A, Kalli F, Svahn J, Stroppiana G, De Rocco D, Terranova P, Dufour C, Fenoglio D, Cappelli E.

Cytokine. 2015 May;73(1):203-7. doi: 10.1016/j.cyto.2015.02.016. Epub 2015 Mar 10.

PMID:
25769809
16.

Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.

Fenoglio D, Parodi A, Lavieri R, Kalli F, Ferrera F, Tagliamacco A, Guastalla A, Lamperti MG, Giacomini M, Filaci G.

Hum Vaccin Immunother. 2015;11(4):838-50. doi: 10.1080/21645515.2015.1012032.

17.

Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate.

Pulliero A, Wu Y, Fenoglio D, Parodi A, Romani M, Soares CP, Filaci G, Lee JL, Sinkam PN, Izzotti A.

Carcinogenesis. 2015 Mar;36(3):368-77. doi: 10.1093/carcin/bgv008. Epub 2015 Feb 3.

PMID:
25653234
18.

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL.

Dentone C, Fenoglio D, Signori A, Cenderello G, Parodi A, Bozzano F, Guerra M, De Leo P, Bartolacci V, Mantia E, Orofino G, Kalli F, Marras F, Fraccaro P, Giacomini M, Cassola G, Bruzzone B, Ferrea G, Viscoli C, Filaci G, De Maria A, Di Biagio A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

19.

ImmunoDB: a web based tool to analyze preclinical data.

Lavieri R, Filaci G, Fenoglio D, Giacomini M.

Stud Health Technol Inform. 2014;205:438-42.

PMID:
25160222
20.

The ligurian human immunodeficiency virus clinical network: a web tool to manage patients with human immunodeficiency virus in primary care and multicenter clinical trials.

Fraccaro P, Pupella V, Gazzarata R, Dentone C, Cenderello G, De Leo P, Bozzano F, Casalino Finocchio G, De Maria A, Fenoglio D, Filaci G, Guerra M, Di Biagio A, Mantia E, Orofino G, Ferrea G, Viscoli C, Giacomini M.

Med 2 0. 2013 Aug 13;2(2):e5. doi: 10.2196/med20.2712. eCollection 2013 Jul-Dec.

21.

Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery.

Pulliero A, Marengo B, Fenoglio D, Parodi A, Cereda C, Domenicotti C, Orcesi S, Galli J, Olivieri I, Filaci G, Balottin U, Fazzi E, Izzotti A.

Microrna. 2014;2(3):187-93.

PMID:
25069442
22.

Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice.

Ferrera F, Fenoglio D, Cutolo M, Balbi G, Parodi A, Battaglia F, Kalli F, Barone D, Indiveri F, Criscuolo D, Filaci G.

Clin Exp Med. 2015 Aug;15(3):255-60. doi: 10.1007/s10238-014-0303-8. Epub 2014 Jul 25.

PMID:
25059463
23.

Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.

Rigo V, Corrias MV, Orengo AM, Brizzolara A, Emionite L, Fenoglio D, Filaci G, Croce M, Ferrini S.

Cancer Immunol Immunother. 2014 May;63(5):501-11. doi: 10.1007/s00262-014-1536-9. Epub 2014 Mar 20.

PMID:
24647609
24.

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients.

Dentone C, Di Biagio A, Parodi A, Bozzano F, Fraccaro P, Signori A, Cenderello G, Mantia E, Orofino G, De Maria A, Filaci G, Fenoglio D.

AIDS. 2014 Apr 24;28(7):1071-4. doi: 10.1097/QAD.0000000000000194.

PMID:
24499952
25.

HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.

Furfaro AL, Piras S, Passalacqua M, Domenicotti C, Parodi A, Fenoglio D, Pronzato MA, Marinari UM, Moretta L, Traverso N, Nitti M.

Biochim Biophys Acta. 2014 Apr;1842(4):613-22. doi: 10.1016/j.bbadis.2013.12.008. Epub 2013 Dec 28.

26.

Generation of more effective cancer vaccines.

Fenoglio D, Traverso P, Parodi A, Kalli F, Zanetti M, Filaci G.

Hum Vaccin Immunother. 2013 Dec;9(12):2543-7. doi: 10.4161/hv.26147. Epub 2013 Aug 26.

27.

Multicentre clinical trials' data management: a hybrid solution to exploit the strengths of electronic data capture and electronic health records systems.

Fraccaro P, Dentone C, Fenoglio D, Giacomini M.

Inform Health Soc Care. 2013 Dec;38(4):313-29. doi: 10.3109/17538157.2013.812648. Epub 2013 Aug 19.

PMID:
23957714
28.

Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice.

Kalli F, Machiorlatti R, Battaglia F, Parodi A, Conteduca G, Ferrera F, Proietti M, Tardito S, Sanguineti M, Millo E, Fenoglio D, De Palma R, Inghirami G, Filaci G.

J Transl Med. 2013 May 12;11:120. doi: 10.1186/1479-5876-11-120.

29.

Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

Serpero LD, Filaci G, Parodi A, Battaglia F, Kalli F, Brogi D, Mancardi GL, Uccelli A, Fenoglio D.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1106-13. doi: 10.1007/s11481-013-9465-5. Epub 2013 May 7.

30.

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.

Fenoglio D, Traverso P, Parodi A, Tomasello L, Negrini S, Kalli F, Battaglia F, Ferrera F, Sciallero S, Murdaca G, Setti M, Sobrero A, Boccardo F, Cittadini G, Puppo F, Criscuolo D, Carmignani G, Indiveri F, Filaci G.

Cancer Immunol Immunother. 2013 Jun;62(6):1041-52. doi: 10.1007/s00262-013-1415-9. Epub 2013 Apr 17.

PMID:
23591981
31.

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.

Parodi A, Battaglia F, Kalli F, Ferrera F, Conteduca G, Tardito S, Stringara S, Ivaldi F, Negrini S, Borgonovo G, Simonato A, Traverso P, Carmignani G, Fenoglio D, Filaci G.

Cancer Immunol Immunother. 2013 May;62(5):851-62. doi: 10.1007/s00262-013-1392-z. Epub 2013 Jan 29.

32.

Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.

Würth R, Pattarozzi A, Gatti M, Bajetto A, Corsaro A, Parodi A, Sirito R, Massollo M, Marini C, Zona G, Fenoglio D, Sambuceti G, Filaci G, Daga A, Barbieri F, Florio T.

Cell Cycle. 2013 Jan 1;12(1):145-56. doi: 10.4161/cc.23050. Epub 2012 Dec 19.

33.

Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis.

Tardito S, Negrini S, Conteduca G, Ferrera F, Parodi A, Battaglia F, Kalli F, Fenoglio D, Cutolo M, Filaci G.

Hum Immunol. 2013 Feb;74(2):166-9. doi: 10.1016/j.humimm.2012.11.008. Epub 2012 Nov 29.

34.

Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata.

Conteduca G, Rossi A, Megiorni F, Parodi A, Ferrera F, Tardito S, Battaglia F, Kalli F, Negrini S, Pizzuti A, Rizza E, Indiveri F, Fenoglio D, Filaci G.

Clin Exp Med. 2014 Feb;14(1):91-7. doi: 10.1007/s10238-012-0224-3. Epub 2012 Nov 30.

35.

Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.

Fenoglio D, Bernuzzi F, Battaglia F, Parodi A, Kalli F, Negrini S, De Palma R, Invernizzi P, Filaci G.

Autoimmun Rev. 2012 Dec;12(2):300-4. doi: 10.1016/j.autrev.2012.05.004. Epub 2012 May 23. Review.

PMID:
22634708
36.

Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro.

Bruzzone S, Battaglia F, Mannino E, Parodi A, Fruscione F, Basile G, Salis A, Sturla L, Negrini S, Kalli F, Stringara S, Filaci G, Zocchi E, Fenoglio D.

Biochem Biophys Res Commun. 2012 May 25;422(1):70-4. doi: 10.1016/j.bbrc.2012.04.107. Epub 2012 Apr 27.

PMID:
22560900
37.

Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.

Traverso I, Fenoglio D, Negrini S, Parodi A, Battaglia F, Kalli F, Conteduca G, Tardito S, Traverso P, Indiveri F, Filaci G.

Hum Immunol. 2012 Mar;73(3):207-13. doi: 10.1016/j.humimm.2011.12.020. Epub 2012 Jan 14.

38.

Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1.

Furfaro AL, Macay JR, Marengo B, Nitti M, Parodi A, Fenoglio D, Marinari UM, Pronzato MA, Domenicotti C, Traverso N.

Free Radic Biol Med. 2012 Jan 15;52(2):488-96. doi: 10.1016/j.freeradbiomed.2011.11.007. Epub 2011 Nov 13.

PMID:
22142473
39.

The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts.

Bruzzone S, Ameri P, Briatore L, Mannino E, Basile G, Andraghetti G, Grozio A, Magnone M, Guida L, Scarfì S, Salis A, Damonte G, Sturla L, Nencioni A, Fenoglio D, Fiory F, Miele C, Beguinot F, Ruvolo V, Bormioli M, Colombo G, Maggi D, Murialdo G, Cordera R, De Flora A, Zocchi E.

FASEB J. 2012 Mar;26(3):1251-60. doi: 10.1096/fj.11-190140. Epub 2011 Nov 10.

PMID:
22075645
40.

MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine.

Fenoglio D, Zocchi MR, Parodi A, Durando P, Gabutitp G, Gasparini R, Poggi A.

J Prev Med Hyg. 2011 Sep;52(3):137-41.

PMID:
22010544
41.

Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.

Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G.

Clin Immunol. 2011 Jun;139(3):249-57. doi: 10.1016/j.clim.2011.01.013. Epub 2011 Feb 2.

42.

Th17 cells and allergic rhinitis: Is there clinical relevance?

Ciprandi G, Filaci G, Fenoglio D.

Otolaryngol Head Neck Surg. 2010 Oct;143(4):604-5. doi: 10.1016/j.otohns.2010.07.005. No abstract available.

PMID:
20869581
43.

CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

Filaci G, Fenoglio D, Indiveri F.

Autoimmunity. 2011 Feb;44(1):51-7. doi: 10.3109/08916931003782171. Epub 2010 Jul 29. Review.

PMID:
20670118
44.

Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P, Filaci G.

J Autoimmun. 2010 Nov;35(3):176-80. doi: 10.1016/j.jaut.2010.06.004. Epub 2010 Jul 16.

45.

Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression.

Vacca P, Cantoni C, Vitale M, Prato C, Canegallo F, Fenoglio D, Ragni N, Moretta L, Mingari MC.

Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11918-23. doi: 10.1073/pnas.1001749107. Epub 2010 Jun 14.

46.

Peripheral TH-17 cells in children with allergic rhinitis: preliminary report.

Ciprandi G, Castellazzi AM, Fenoglio D, Battaglia F, Marseglia G.

Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):379-82.

PMID:
20378028
47.

The role of AIRE polymorphisms in melanoma.

Conteduca G, Ferrera F, Pastorino L, Fenoglio D, Negrini S, Sormani MP, Indiveri F, Scarrà GB, Filaci G.

Clin Immunol. 2010 Jul;136(1):96-104. doi: 10.1016/j.clim.2010.03.002. Epub 2010 Apr 2.

48.

Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths.

Rosso R, Fenoglio D, Terranova MP, Lantieri F, Risso D, Pontali E, Setti M, Cossarizza A, Ravetti JL, Viscoli C, Kunkl A.

Scand J Immunol. 2010 Jan;71(1):45-51. doi: 10.1111/j.1365-3083.2009.02345.x.

49.

Peripheral Th-17 cells in allergic rhinitis: New evidence.

Ciprandi G, Filaci G, Battaglia F, Fenoglio D.

Int Immunopharmacol. 2010 Feb;10(2):226-9. doi: 10.1016/j.intimp.2009.11.004. Epub 2009 Nov 16.

PMID:
19925886
50.

Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone.

Costa P, Bozzano F, Fenoglio D, Beltrame A, Cenderello G, Di Biagio A, Ferrea G, Pagano G, De Maria A.

Clin Exp Immunol. 2009 Oct;158(1):55-63. doi: 10.1111/j.1365-2249.2009.03988.x.

Supplemental Content

Loading ...
Support Center